Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • coronavirus update

Tag: coronavirus update

  • BiotechToday
  • World

Airborne Pollen hypothesized as ideal COVID-19 carrier

bioxone June 28, 2021June 27, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi The concept of viral infection focuses on the transmission of viral particles from one individual and infecting someone close in contact. Researchers across the globe have created theories to explain the high prevalence of COVID-19 infection from the beginning of the crisis. They discovered that viral particles may […]

Read More
  • BiotechToday
  • India

COVAXIN : India’s preparation for massive vaccination drive.

bioxone January 10, 2021January 9, 2021

-Chitra Roy, University of Calcutta Covaxin, India’s indigenous COVID-19 vaccine, has been a subject of criticism due to its approval for restricted emergency use despite hot having published any phase 3 efficacy data. However, until recently, Bharat Biotech, the manufacturer of Covaxin claimed that its vaccine potentially generated safety data with the robust immune response […]

Read More
  • BiotechToday
  • World

RC-PCR technology in SARS-Cov-2: Mega-Analyzer for outbreaks

bioxone November 1, 2020November 1, 2020 1

 Ayooshi Mitra, Amity University Kolkata Present transmission rates of SARS-CoV-2 are still on the rise, with second waves of infections being faced by many countries. Rapid SARS-CoV-2 whole-genome sequencing (WGS) is a massive tool for tracking and assessing transmission links but is not so readily available.  In a study conducted by a group of researchers, […]

Read More
  • BiotechToday
  • India
  • World

Covid Update: Moderna Vaccine on the Horizon!

bioxone October 20, 2020October 20, 2020

Chitra Roy, University of Calcutta An American biotechnology company ‘Moderna’, based in Cambridge, Massachusetts focuses on the discovery and development of drugs in addition to vaccine technologies. They exclusively use messenger RNA (mRNA) therapeutics and designs vaccines to create a completely new generation of transformative medicines. Against COVID-19, Moderna has developed its mRNA vaccine candidate […]

Read More
  • BiotechToday
  • World

Is Covid-19 being partial towards certain blood groups

bioxone October 16, 2020October 16, 2020

Ayooshi Mitra, Amity University Kolkata Study claims that individuals with blood type O are less inclined to get affected by the novel Coronavirus. For such blood type, developing symptoms like organ failures are also low. Nevertheless, individuals with blood groups A and AB are more susceptible to procuring this infection. There have been several studies […]

Read More
  • BiotechToday
  • India

COVID UPDATE: Decrease in daily active cases in India

bioxone October 13, 2020October 13, 2020

Camelia Bhattacharyya, Amity University Kolkata The coronavirus, or the virus which has resulted in the whole world to shutdown, the ecosystem to change and us to depend completely on technology (to manage the economic conditions) and their immunity (since its more or less the survival of the fittest) first started its game in Wuhan, China. […]

Read More
  • BiotechToday
  • India

Unique transmission mode of Covid-19 in India

bioxone October 2, 2020October 2, 2020 10

-Husna, Amity University Kolkata The detailed study of SARS-CoV2 transmission patterns in India has revealed that over 70% of those who contract Covid-19 don’t pass it on any further, while a minority act as super-spreaders. The global study using the largest dataset of contacts, also shows that children play a major role in the transmission […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy

Protected by Malware Removal